Allergan
Allergan settles gender discrimination case for $4m
October 11, 2017Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical
It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …
Shire takes fight to Allergan over dry-eye drug
October 4, 2017Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical
It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …
Top Ten most popular articles on Pharmafile.com this week
September 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, EMA, FDA, HIV, J&J, JJ, Kevzara, Mylan, NICE, Sanofi, nash, top ten
It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …
Allergan’s Executive VP and Chief Financial Officer steps down
September 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, appointment
Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …
Allergan posts disappointing data in NASH
September 25, 2017Research and Development, Sales and Marketing Allergan, biotech, drugs, nash, pharma, pharmaceutical
It was only last year that Allergan decided to cough up $1.7 billion to acquire Tobira Therapeutics, with the main …
New data shows pharma has not cut back on controversial payments to physicians
July 6, 2017Medical Communications, Sales and Marketing Allergan, Biogen, Celgene, Sanofi, Valeant
Despite increasing controversy arising over the years due to the questionable relationship between physicians and pharma and the money which …
Allergan and Novartis join forces to develop NASH combo therapy
April 18, 2017Manufacturing and Production, Research and Development Allergan, Novartis, nash
Allergan and Novartis have announced a new partnership to conduct a clinical trial in the treatment area of non-alcoholic steatohepatitis …
Relay Therapeutics appoints Allergan CSO to CEO position
April 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Relay
Relay Therapeutics, a biotech firm launched in September 2016, has announced that Sanjiv K. Patel will be its CEO. Patel …
Allergan set to bolster ‘medical aesthetics’ unit with $2.5 billion Zeltiq deal
February 13, 2017Manufacturing and Production, Sales and Marketing Allergan, FDA, Zeltiq
Allergan, the owner of Botox, has expanded its stake in the ‘medical aesthetics’ business by acquiring Zeltiq Aesthetics. Zeltiq has …
Allergan successfully completes $2.9bn LifeCell acquisition
February 2, 2017Business Services, Sales and Marketing Allergan, LifeCell
The acquisition of regenerative medicine firm LifeCell by Allergan for $2.9 billion announced back in December has been completely successfully, …
Allergan fined £15m over failure to disclose merger discussions
January 19, 2017Sales and Marketing Allergan, SEC
Allergan has been fined $15 million by the Security and Exchange Commission (SEC) after committing disclosure violations during merger talks …
Allergan shells out $2.9bn for regenerative medicine unit LifeCell
December 21, 2016Research and Development, Sales and Marketing Allergan, LifeCell, acquisition
Allergan has agreed a deal to acquire Acelity-owned regenerative medicine unit LifeCell for $2.9 billion in cash, assimilating its portfolio …
Teva to shut down Maltese plant, axe 210 jobs
November 30, 2016Manufacturing and Production, Research and Development Actavis Generics, Allergan, Malta, Teva
Teva is set to axe 210 jobs and shut down a production plant in Malta in an effort to cut …
Allergan appoints Adriane M. Brown to board of directors
November 14, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan
Allergan announced that Adriana M. Brown will join its board of directors on February 2017. Adriana Brown is currently the …
Allergan in $200 million purchase of biopharmaceutical
October 28, 2016Medical Communications Allergan, Motus Therapeutics, Rythm Holding, Teva
Allergan will acquire Motus Therapeautics, a biopharmaceutical company that specialises in developing treatments for gastroparesis. It is another acquisition that …
Latest content
FibroFind appoints Lee Borthwick as CEO
